cell-mediated immunity

(redirected from Cell response)
Also found in: Dictionary, Encyclopedia.

cell-·me·di·at·ed im·mu·ni·ty (CMI),

, cellular immunity
Immune responses mediated by activated, antigen-specific T lymphocytes. These T cells may function as effector cells or may orchestrate propagation of the inflammatory response and cellular recruitment through their secretion of cytokines and chemokines.
Synonym(s): delayed hypersensitivity (1)

cell-mediated immunity

n.
Immunity resulting from a cell-mediated immune response. Also called cellular immunity.

cell-mediated immunity

cell-me·di·at·ed im·mu·ni·ty

, cellular immunity (CMI) (sel'mē'dē-āt-ĕd i-myū'ni-tē, sel'yū-lăr)
Immune responses that are initiated by T lymphocytes and mediated by T lymphocytes, macrophages, or both (e.g., graft rejection, delayed-type hypersensitivity).
Enlarge picture
CELL-MEDIATED IMMUNITY

cell-mediated immunity

Abbreviation: CMI.
The regulatory and cytotoxic activities of T cells during the specific immune response. This process requires about 36 hr to reach its full effect. Synonym: T-cell–mediated immunity See: illustration; humoral immunity

Unlike B cells, T cells cannot recognize foreign antigens on their own. Foreign antigens are recognized by antigen-presenting cells (APCs) such as macrophages, which engulf them and display part of the antigens on the APC's surface next to a histocompatibility or “self-” antigen (macrophage processing). The presence of these two markers, plus the cytokine interleukin-1 (IL-1) secreted by the APCs activates CD4 helper T cells (TH cells), which regulate the activities of other cells involved in the immune response.

CMI includes direct lysis of target cells by cytotoxic T cells, creation of memory cells that trigger a rapid response when a foreign antigen is encountered for the second time, and delayed hypersensitivity to tissue and organ transplants. T cells also stimulate the activity of macrophages, B cells, and natural killer cells. These functions are controlled largely by the secretion of lymphokines such as the interleukins, interferons, and colony-stimulating factors. Lymphokines facilitate communication and proliferation of the cells in the immune system.

See also: immunity

cell-mediated immunity

Action by the immune system involving T cells (T LYMPHOCYTES) and concerned with protection against viruses, fungi, TUBERCULOSIS and cancers and rejection of foreign grafted material. Cell-mediated immunity is not primarily effected by ANTIBODIES.

cell-mediated

effected by cellular rather than chemical elements.

cell-mediated hypersensitivity
see delayed hypersensitivity.
cell-mediated immunity
see cellular immunity.
cell-mediated lympholysis assay
a test of cell-mediated immunity in which activated cytoxic T lymphocytes cause lysis of 51Cr-labeled target cells.
References in periodicals archive ?
Our study provides encouraging immunologic and clinical data that Inovios immunotherapy product can generate antigen-specific CD8+ killer T cell responses in the blood and link such responses to PSA changes in prostate cancer patients.
The dependence of the load cell response upon previously applied forces and upon the degree of misalignment of the applied force relative to the load cell axis then becomes evident, both in the quantity [u.
The Antigen Express vaccine could be used to prime T helper cell responses to a recombinant protein of H5 hemaglutinin.
today announced an interim data analysis showing that its INO-3112 cancer immunotherapy product generated antigen-specific CD8+ killer T cell responses measured both in tumor tissue and in peripheral blood from subjects with head and neck cancer associated with human papillomavirus (HPV).
A 5-mg dose that uses the CRL 1005 adjuvant consistently showed the best results, with CD8 T cell responses in particular, in rhesus monkeys immunized at 0, 4, and 8 weeks.
Genocea Biosciences is a vaccine discovery and development company targeting major infectious diseases with high unmet medical needs, in which T cell responses help confer protection.
Virus-specific cytotoxic T cell responses increased significantly after both treatment interruptions and expanded to target more viral epitopes.
The contract is for the microbiological analysis of air samples, dust and surface habitats in Brussels in support of the activities of the regional cell response indoor pollution.
Recent reports from Steven Deeks, MD,[15] stating that CD4 T cell response is sustained even after the failure of PI-based regimens lend a further dimension to the issue, posing the question of whether there is some inherent benefit of PIs or PI-based regimens that makes them useful even beyond their obvious mechanism of suppressing HIV.
However, the researchers found that restoring the gene for that protein alone wasn't enough to strengthen T cell response against TB.
A third study showed a strong CD4 T cell response during PHI, which was conserved in patients who received treatment, but was "strongly" reduced in untreated patients (Abstract 583).
Fauci's international team studied the T cell response in 21 people infected with HIV.